2022 Zoetis Annual Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:
The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:
- Latest organizational and management developments
- Acquisitions and divestitures
- Marketing tactics
- Financial results
- Strengths and weaknesses
- Strategic directions
- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis their major competitors.
- To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.
- To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.
More Publications
Gilead Sciences Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
US$ 750.00
October 2021
-
2021 Vertex Pharmaceuticals SWOT Analysis-Performance, Capabilities, Goals and Strategies
US$ 750.00
January 2021
-
2019 Pharmaceutical Competitive Intelligence: Vertex Pharmaceuticals Performance, Capabilities, Goals and Strategies
US$ 950.00
February 2019
-
The 2011 Leading Pharmaceutical Companies Collaborative Arrangements
US$ 1,480.00
October 2010
200 pages
Virbac: 2017-2021 Global Animal Health Market Segment Forecasts and Company's Strategic Assessment
US$ 750.00
December 2017
-
